DocDollars

Beigene, Ltd.

Cayman Islands · Reporting entity ID 100000826833

Total reported 2019–2025
$346.3M
#45 of 2,960 reporting companies — 0.4% of all reported industry payments
$2.10M in general payments across 572 records, plus $343.8M in research funding across 25,924 records.

How it breaks down

General payments $2,098,694
Research funding $343,774,833
Ownership & investment $448,941

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Beigene, Ltd. reported $346.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #45 of 2,960 reporting companies. 99% of that was research funding and 1% general payments such as consulting, speaking, food and travel. 572 general payment records and 25,924 research records were filed.

Common questions about Beigene, Ltd.

How much has Beigene, Ltd. paid US doctors?

Beigene, Ltd. reported $346,322,469 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,098,694 in general payments, $343,774,833 in research funding and $448,941 in ownership and investment interests.

How does Beigene, Ltd. rank among drug and device companies?

It ranks #45 of 2,960 reporting entities by total reported value, about 0.4% of all industry payments in the dataset.

Does a payment from Beigene, Ltd. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.